| Alicia M Dessanti, MS OTR/L | |
|
38 Mcelwain St, Merrimack, NH 03054-3663 | |
| (603) 424-6204 | |
| Not Available |
| Full Name | Alicia M Dessanti |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist |
| Location | 38 Mcelwain St, Merrimack, New Hampshire |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093155681 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Alicia M Dessanti, MS OTR/L 9 Barr Farm Rd, Bedford, NH 03110-5221 Ph: () - | Alicia M Dessanti, MS OTR/L 38 Mcelwain St, Merrimack, NH 03054-3663 Ph: (603) 424-6204 |
News Archive
Anthera Pharmaceuticals, Inc., a privately held biopharmaceutical company developing drugs to treat serious diseases associated with inflammation, announced today that it reached an agreement with the U.S. Food and Drug Administration (FDA) on a Special Protocol Assessment (SPA) for the Phase 3 clinical study named VISTA-16 (Vascular Inflammation Suppression to Treat Acute Coronary Syndrome - 16 Weeks) for its lead product candidate, A-002, an oral sPLA2 inhibitor, in combination with HMG-CoA reductase inhibitor, or statin, therapy for short-term (16-week) treatment of patients experiencing an acute coronary syndrome.
Both organizations are already collaborating on several projects, including the mapping of the genomes of more than 1,000 species of gut bacteria, compiled from 577 billion base pairs of sequence data. The leading scientific journal Science selected this work as one of the scientific breakthroughs of 2011. Large-scale genome sequencing is becoming ever more important in life sciences, healthcare and agricultural research.
Ever since the early days of the health-care reform law, its supporters have argued that there is a "conservative" argument to be made for the constitutionality of the law.
Over the years, the Centers for Disease Control and its partners have made major progress towards reducing lead exposure in the United States. But more work remains in preventing lead poisoning in US children and adults, according to a special supplement to the Journal of Public Health Management and Practice. The journal is published in the Lippincott portfolio by Wolters Kluwer.
› Verified 4 days ago
Ms. Diane Daniels, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 370 Daniel Webster Hwy, Unit 1, Merrimack, NH 03054 Phone: 603-424-1950 Fax: 603-424-4749 | |
Jillian Fillip, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 9 Erik St, Merrimack, NH 03054 Phone: 603-305-3919 | |
Heather Elizabeth Sayward, MS OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 15 Clay St, Merrimack, NH 03054 Phone: 508-873-0028 | |
Meghan Mcgrath, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1 Whitewood Ln, Merrimack, NH 03054 Phone: 603-315-3247 | |
Lydia A Closson, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 32 Daniel Webster Hwy Ste 16, Merrimack, NH 03054 Phone: 603-589-9184 | |
Kristen Nicole Kenny, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 36 Mcelwain St, Merrimack, NH 03054 Phone: 603-524-9090 |